National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams)
Clinical trials sponsored by National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams), explained in plain language.
-
Promising psoriasis drug fails to launch in muscle disease trial
Disease control TerminatedThis study planned to test deucravacitinib, a pill already approved for psoriasis, in adults with dermatomyositis or juvenile dermatomyositis that did not respond to standard treatments. The goal was to see if the drug could improve muscle and skin symptoms. However, the study wa…
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Massive data dive aims to make joint replacement safer
Knowledge-focused OngoingThis study reviews medical records from over 500,000 Medicare patients who had major orthopedic surgeries like hip or knee replacements. The goal is to find patterns in complications and see if care has improved over time. No new treatments are tested; instead, researchers hope t…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC